Stephanie Daignault

7.0k total citations · 1 hit paper
123 papers, 5.1k citations indexed

About

Stephanie Daignault is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Stephanie Daignault has authored 123 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Pulmonary and Respiratory Medicine, 40 papers in Oncology and 36 papers in Surgery. Recurrent topics in Stephanie Daignault's work include Prostate Cancer Treatment and Research (34 papers), Bladder and Urothelial Cancer Treatments (26 papers) and Prostate Cancer Diagnosis and Treatment (19 papers). Stephanie Daignault is often cited by papers focused on Prostate Cancer Treatment and Research (34 papers), Bladder and Urothelial Cancer Treatments (26 papers) and Prostate Cancer Diagnosis and Treatment (19 papers). Stephanie Daignault collaborates with scholars based in United States, Israel and Germany. Stephanie Daignault's co-authors include Brent K. Hollenbeck, David C. Miller, John M. Hollingsworth, Cheryl T. Lee, Rajal B. Shah, Rodney L. Dunn, Yingxi Zhang, Khaled S. Hafez, Lakshmi P. Kunju and John T. Wei and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Stephanie Daignault

121 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rising Incidence of Small Renal Masses: A Need to Reassess Treatment Effect

2006 859 citations John M. Hollingsworth, David C. Miller et al. JNCI Journal of the National Cancer Institute profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephanie Daignault United States	36	2.5k	2.0k	1.7k	1.2k	670	123	5.1k
Andrea Haitel Austria	42	2.3k 0.9×	2.0k 1.0×	1.7k 1.1×	1.1k 0.9×	849 1.3×	153	5.3k
C.C. Abbou France	40	2.5k 1.0×	2.0k 1.0×	2.3k 1.4×	678 0.6×	684 1.0×	139	5.0k
Thomas E. Keane United States	33	2.5k 1.0×	1.8k 0.9×	1.3k 0.8×	718 0.6×	402 0.6×	126	4.3k
Grant D. Stewart United Kingdom	35	2.2k 0.9×	1.8k 0.9×	1.3k 0.8×	813 0.7×	917 1.4×	225	4.7k
Shin Egawa Japan	40	3.7k 1.5×	1.7k 0.8×	1.4k 0.8×	1.3k 1.1×	1.2k 1.8×	360	6.4k
Karim Chamie United States	34	1.7k 0.7×	1.4k 0.7×	2.5k 1.5×	1.3k 1.1×	666 1.0×	183	5.1k
Gary D. Grossfeld United States	48	3.4k 1.4×	1.1k 0.6×	1.9k 1.1×	1.4k 1.1×	662 1.0×	123	6.0k
Christer Busch Sweden	33	3.5k 1.4×	1.3k 0.6×	2.6k 1.5×	1.3k 1.0×	621 0.9×	106	6.8k
Marc Zerbib France	34	2.3k 0.9×	862 0.4×	2.0k 1.2×	776 0.6×	513 0.8×	262	4.7k
Richard E. Greenberg United States	44	4.6k 1.9×	3.0k 1.5×	2.2k 1.3×	1.1k 0.9×	1.2k 1.7×	200	7.1k

Countries citing papers authored by Stephanie Daignault

Since Specialization

Citations

This map shows the geographic impact of Stephanie Daignault's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephanie Daignault with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephanie Daignault more than expected).

Fields of papers citing papers by Stephanie Daignault

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephanie Daignault. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephanie Daignault. The network helps show where Stephanie Daignault may publish in the future.

Co-authorship network of co-authors of Stephanie Daignault

This figure shows the co-authorship network connecting the top 25 collaborators of Stephanie Daignault. A scholar is included among the top collaborators of Stephanie Daignault based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephanie Daignault. Stephanie Daignault is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Krishna, Suprita, Stephanie Daignault, Richard Sarle, et al.. (2025). Newly Developed Hydronephrosis in Patients Following Ureteroscopy: Who Is at Risk?. Journal of Endourology. 39(8). 759–765.

Jorns, Julie M., Stephanie Daignault, Michael S. Sabel, Jeffrey L. Myers, & Angela Wu. (2017). Frozen sections in patients undergoing breast conserving surgery at a single ambulatory surgical center: 5 year experience. European Journal of Surgical Oncology. 43(7). 1273–1281. 12 indexed citations

Palmbos, Phillip L., Lidong Wang, Huibin Yang, et al.. (2015). ATDC/TRIM29 Drives Invasive Bladder Cancer Formation through miRNA-Mediated and Epigenetic Mechanisms. Cancer Research. 75(23). 5155–5166. 60 indexed citations

Jorns, Julie M., Dafydd G. Thomas, Patrick Healy, et al.. (2014). Estrogen Receptor Expression Is High but Is of Lower Intensity in Tubular Carcinoma Than in Well-Differentiated Invasive Ductal Carcinoma. Archives of Pathology & Laboratory Medicine. 138(11). 1507–1513. 2 indexed citations

Kunju, Lakshmi P., Nallasivam Palanisamy, Stephanie Daignault, et al.. (2014). Concordance of ETS fusion status of matched metastatic castration-resistant prostate cancer and primary prostate cancer: Data from NCI 9012, a randomized ETS fusion-stratified phase II trial.. Journal of Clinical Oncology. 32(15_suppl). 5019–5019. 2 indexed citations

Park, Serk In, Changki Lee, W. David Sadler, et al.. (2013). Parathyroid Hormone–Related Protein Drives a CD11b+Gr1+ Cell–Mediated Positive Feedback Loop to Support Prostate Cancer Growth. Cancer Research. 73(22). 6574–6583. 46 indexed citations

Kunju, Lakshmi P., et al.. (2013). The E2F1/DNMT1 axis is associated with the development of AR negative castration resistant prostate cancer. The Prostate. 73(16). 1776–1785. 21 indexed citations

Healy, Patrick, et al.. (2013). Cigarette Smoking and Gemcitabine-Induced Neutropenia in Advanced Solid Tumors. Oncology. 85(4). 216–222. 17 indexed citations

Park, Serk In, Jinhui Liao, Janice E. Berry, et al.. (2012). Cyclophosphamide Creates a Receptive Microenvironment for Prostate Cancer Skeletal Metastasis. Cancer Research. 72(10). 2522–2532. 58 indexed citations

10.

Ren, Gang, Stavroula Baritaki, Himangi Marathe, et al.. (2012). Polycomb Protein EZH2 Regulates Tumor Invasion via the Transcriptional Repression of the Metastasis Suppressor RKIP in Breast and Prostate Cancer. Cancer Research. 72(12). 3091–3104. 184 indexed citations

11.

Schneider, Bryan J., Shirish M. Gadgeel, Nithya Ramnath, et al.. (2011). Phase II Trial of Sunitinib Maintenance Therapy After Platinum-Based Chemotherapy in Patients with Extensive-Stage Small Cell Lung Cancer. Journal of Thoracic Oncology. 6(6). 1117–1120. 25 indexed citations

12.

Soto, Daniel E., Michael N. Passarelli, Stephanie Daignault, & Howard M. Sandler. (2011). Concurrent Androgen Deprivation Therapy During Salvage Prostate Radiotherapy Improves Treatment Outcomes in High-Risk Patients. International Journal of Radiation Oncology*Biology*Physics. 82(3). 1227–1232. 28 indexed citations

13.

Alva, Ajjai, Susan F. Slovin, Stephanie Daignault, et al.. (2010). Phase II study of Cilengitide (EMD 121974, NSC 707544) in patients with non-metastatic castration resistant prostate cancer, NCI-6735. A study by the DOD/PCF prostate cancer clinical trials consortium. Investigational New Drugs. 30(2). 749–757. 72 indexed citations

14.

Ignatoski, Kathleen M. Woods, June Escara‐Wilke, Xiaohua Zhang, et al.. (2008). Change in Markers of Bone Metabolism with Chemotherapy for Advanced Prostate Cancer: Interleukin-6 Response Is a Potential Early Indicator of Response to Therapy. Journal of Interferon & Cytokine Research. 29(2). 105–111. 22 indexed citations

15.

Kim, Yun‐Gi, Jong‐Hwan Park, Stephanie Daignault, Koichi Fukase, & Gabriel Núñez. (2008). Cross-Tolerization between Nod1 and Nod2 Signaling Results in Reduced Refractoriness to Bacterial Infection in Nod2-Deficient Macrophages. The Journal of Immunology. 181(6). 4340–4346. 32 indexed citations

16.

Gilbert, Scott M., Rodney L. Dunn, David C. Miller, et al.. (2008). Mortality After Urologic Cancer Surgery: Impact of Non-index Case Volume. Urology. 71(5). 906–910. 26 indexed citations

17.

Miller, David C., Stephanie Daignault, J. Stuart Wolf, et al.. (2008). Hospital Characteristics and Use of Innovative Surgical Therapies Among Patients With Kidney Cancer. Medical Care. 46(4). 372–379. 27 indexed citations

18.

McCabe, Michael T., Jonathan Low, Stephanie Daignault, et al.. (2006). Inhibition of DNA Methyltransferase Activity Prevents Tumorigenesis in a Mouse Model of Prostate Cancer. Cancer Research. 66(1). 385–392. 113 indexed citations

19.

Gilbert, Scott M., Stephanie Daignault, & Aruna V. Sarma. (2006). 135: Prostate Cancer Incidence and Mortality: Forecasting Trends in the Post-PSA ERA. The Journal of Urology. 175(4S). 43–43. 1 indexed citations

20.

Hollingsworth, John M., David C. Miller, Stephanie Daignault, & Brent K. Hollenbeck. (2006). Rising Incidence of Small Renal Masses: A Need to Reassess Treatment Effect. JNCI Journal of the National Cancer Institute. 98(18). 1331–1334. 859 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact